Ze H. Chen
Shanghai, 200031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Evidence for Water-Borne Transmission of Highly Pathogenic Avian Influenza H5N1 Viruses.
Journal: Frontiers in microbiology
Published: March 15, 2022
A new protein-coupled antigen of α-conotoxin MI displays high immunogenicity and can produce antiserum with high detoxification activity.
Journal: Toxicon : official journal of the International Society on Toxinology
Published: November 01, 2021
Development and validation of a ligand-binding assay for quantification of the F(ab')2 antivenom of Daboia russelii siamensis in human serum and its application to a phase I clinical study.
Journal: Journal of pharmaceutical and biomedical analysis
Published: September 09, 2021
Protein transduction domain-mediated influenza NP subunit vaccine generates a potent immune response and protection against influenza virus in mice.
Journal: Emerging microbes & infections
Published: August 20, 2020
Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro.
Journal: Antiviral research
Published: May 15, 2020
Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: February 03, 2020
Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection.
Journal: Emerging microbes & infections
Published: January 03, 2020
MiRNA Targeted NP Genome of Live Attenuated Influenza Vaccines Provide Cross-Protection against a Lethal Influenza Virus Infection.
Journal: Vaccines
Published: November 28, 2019
Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant.
Journal: Frontiers in immunology
Published: June 11, 2019
Protection against homo and hetero-subtypic influenza A virus by optimized M2e DNA vaccine.
Journal: Emerging microbes & infections
Published: March 15, 2019
Immunization with DNA prime-subunit protein boost strategy based on influenza H9N2 virus conserved matrix protein M1 and its epitope screening.
Journal: Scientific reports
Published: October 08, 2018
Last Updated: 09/26/2026